5-1260508-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 6P and 2B. PM1PM2PM5BP4_Moderate
The NM_198253.3(TERT):c.2936G>A(p.Arg979Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000752 in 1,461,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R979W) has been classified as Pathogenic.
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.2936G>A | p.Arg979Gln | missense_variant | 12/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.2747G>A | p.Arg916Gln | missense_variant | 11/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.2644G>A | non_coding_transcript_exon_variant | 9/13 | ||||
TERT | NR_149163.3 | n.2608G>A | non_coding_transcript_exon_variant | 9/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERT | ENST00000310581.10 | c.2936G>A | p.Arg979Gln | missense_variant | 12/16 | 1 | NM_198253.3 | ENSP00000309572 | P2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461820Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727210
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 04, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 26, 2017 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg979Gln variant in TERT has been reported in one individual with features of dyskeratos is congenita and in an unaffected parent (Collopy 2015). It has also been identi fied in 1/111716 European chromosomes by the Genome Aggregation Database (gnomAD , http://gnomad.broadinstitute.org; dbSNP rs765566930). In vitro functional stud ies show that the variant results in reduced telomerase activity which is at 35% of that observed in wild type cells (Collopy 2015). Computational prediction to ols and conservation analysis provide conflicting predictions on impact of the v ariant to the protein. Splice prediction tools suggest creation of a novel crypt ic splice site that may impact normal splicing; however, glutamine (Gln) at this position is also present 3 mammals (cow, sheep, and antelope), raising the poss ibility that this change may be tolerated. In summary, while there is some suspi cion for a pathogenic role, the clinical significance of the p.Arg979Gln variant is uncertain. ACMG/AMP Criteria applied: PM2; PS4_Supporting. - |
Dyskeratosis congenita, autosomal dominant 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Aug 06, 2019 | This TERT variant (rs765566930) is rare (<0.1%) in one large population dataset and absent from another (ExAC: 1/120770 total alleles; 0.000008%; no homozygotes). A single submitter in ClinVar classifies this variant as a variant of uncertain clinical significance. This variant has been reported in a patient with clinical findings consistent with dyskeratosis congenita, and functional studies suggest that this substitution may impact telomerase activity. The arginine reside at this position is predicted to be in the TERT nuclear export signal. An alternate missense change at this position (p.Arg979Trp) has been identified in a patient with aplastic anemia and may affect telomerase function. If the patient meets the clinical diagnostic criteria for telomere shortening disorders, c.2936G>A is likely the molecular cause of to disease9. - |
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 06, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 979 of the TERT protein (p.Arg979Gln). This variant is present in population databases (rs765566930, gnomAD 0.0009%). This missense change has been observed in individual(s) with dyskeratosis congenita (PMID: 26024875). ClinVar contains an entry for this variant (Variation ID: 506255). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on TERT function (PMID: 26024875). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at